Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
This Research in Action article was provided to LiveScience in partnership with the National Science Foundation.
Thanks to a substantial drop in the cost of DNA sequencing, a human genome, and the new supercomputers and next-generation gene sequencers, scientists are better understanding our DNA and how biological systems and disease relate.
Vishy Iyer of the University of Texas and his colleagues are beginning to investigate transcription factor proteins and their role in gene sequencing. The proteins bind to and regulate genes — turning a gene off or on and determining the activity level of the gene. Understanding how those proteins regulate genes will assist the study of diseases.
Using supercomputers and gene-sequencers, Iyer and colleagues at Duke, the University of North Carolina-Chapel Hill and Hinxton in the UK determined that transcription-factor binding is affected by differences in DNA and that those differences can be inherited.
The team concentrated only on the sections of DNA where the transcription factor proteins bind. ChIP-Seq, a sequencing technology, generated sequence reads containing the order of the nucleotides — molecules that link to form the building blocks of DNA or RNA — and the number of molecules bound. The Ranger Supercomputer, funded by the National Science Foundation, aligned the reads to the reference genome. Scientists could then study how genes and transcription proteins bind on a chromosome by looking at the known differences in DNA shown on the sequence reads.
This research has the potential to enable personalized medicine based on an individual's genome.
For the full story, see the Behind the Scenes article, "Placing Landmarks on the Genome Map."
Get the world’s most fascinating discoveries delivered straight to your inbox.
Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author and do not necessarily reflect the views of the National Science Foundation. See the Research in Action archive.
